Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Reunion Neuroscience Inc
T.REUN
Healthcare
Biotechnology
Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a...
psychedelic drug being developed for post-partum and treatment resistant depression as a potential fast-acting antidepressant with durable efficacy. The RE104 as a potentially fast-acting treatment for the key indications of postpartum and treatment resistant depression. The Company is developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psych activity for potential use in more chronic treatment paradigms and indications. The Company is focused on the research and development of its RE200 molecule group.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:REUN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(44)
•••
evilballs
X
View Profile
View Bullboard History
Comment by
evilballs
on Feb 12, 2021 1:59am
RE:Fieldtrip
Its worth every penny considering this company is on track to grow by aquisition.
(0)
•••
BayStBullshit
X
View Profile
View Bullboard History
Post by
BayStBullshit
on Feb 12, 2021 12:26am
Fieldtrip
The stock seems like it's on a run now. Do you think there's some good fundamentals supporting this or is it a good time to cash out?
(44)
•••
evilballs
X
View Profile
View Bullboard History
Comment by
evilballs
on Feb 05, 2021 5:29pm
RE:3 Reasons to Buy MMED
nice long winded rant, but it appears to me that most of the FDA trials are being held at clinics that Field Trip owns.... to rebutt.... MMED will only succeed if FTRP succeeds first. It
...more
(16)
•••
BillyKnowsBest
X
View Profile
View Bullboard History
Post by
BillyKnowsBest
on Jan 26, 2021 12:41pm
3 Reasons to Buy MMED
Full disclosure MMED is the only company I have an interest in currently in the psychedelic sector, and here are a few points as to why they are the horse I'm backing Clinical Trials team
...more
(14)
•••
SmallCapIntel
X
View Profile
View Bullboard History
Post by
SmallCapIntel
on Jan 18, 2021 8:03am
Updated & In-depth Psychedelics Stocks Index Jan 18!
Check out the biggest gainers and pullbacks from last week in this space: https://twitter.com/SagacityCm/status/1351150366071681025
(14)
•••
SmallCapIntel
X
View Profile
View Bullboard History
Post by
SmallCapIntel
on Jan 11, 2021 8:25am
Updated & In-depth Psychedelics Stocks Index Jan 11
Found this to be useful at finding what Psych plays are out there and comparing SP & MC of each one: https://twitter.com/SagacityCm/status/1348609566519529472
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Jan 05, 2021 10:13am
Field Trip Health Closes $20.0 Million Bought Deal
Field Trip Health this morning announced the closing of its bought deal financing, raising gross proceeds of $20.0 million. The closing is notable, given that the placement took place at $4.50 per
...more
(14)
•••
SmallCapIntel
X
View Profile
View Bullboard History
Post by
SmallCapIntel
on Jan 04, 2021 8:26am
Updated & Indepth Psychedelics Stocks Index
Found this index that outlines all of the psychedelics stocks and tracks their SP/MC to compare the industry players with. https://twitter.com/SagacityCm/status/1346078192134709248
(2)
•••
GFS1954
X
View Profile
View Bullboard History
Post by
GFS1954
on Dec 08, 2020 12:28pm
Holding period on FTRP and industry
I picked up a small position in this company a few weeks back at $2.70. I recognize this is a new firm, very well run, in a new frontier. What are thoughts on price of this stock 1-3 years out, in a
...more
(9)
•••
Rakaposhi
X
View Profile
View Bullboard History
Post by
Rakaposhi
on Dec 07, 2020 10:48am
Common shareholders / directors
It seems the Stang family is deeply involved in this play, as they are in Delic Holdings. Wonder if there is going to be any cross fertilization here .. ?
(17)
•••
PsilocybinAlpha
X
View Profile
View Bullboard History
Post by
PsilocybinAlpha
on Dec 03, 2020 8:24am
FTRP investor update
- Expanded Hours at its Field Trip Health Center in Toronto - Rollout of Portal - Company's Proprietary Digital Mental Health Platform - Field Trip also explained that they're exploring
...more
(17)
•••
PsilocybinAlpha
X
View Profile
View Bullboard History
Post by
PsilocybinAlpha
on Nov 30, 2020 5:13pm
Field Trip Reports Q2 '20 Financials, $14m cash position
Full financials
(117)
•••
MrAMG7
X
View Profile
View Bullboard History
Post by
MrAMG7
on Nov 27, 2020 12:58am
RED LIGHT HOLLAND (TRIP) IS THE Best Buy PICK
Red Light Holland is the future for psychedelics! 10 million volume 20m shares issued! Only at 12 cents.. Will hit $1 in weeks.
(3)
•••
ExoticPlants
X
View Profile
View Bullboard History
Post by
ExoticPlants
on Nov 26, 2020 3:20am
Save 15-20% @ Herb Approach + Black Friday Sale
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #454545} span.s1 {text-decoration: underline ; color: #e4af09} Take advantage of massive Black Friday sales and save an
...more
(17)
•••
PsilocybinAlpha
X
View Profile
View Bullboard History
Post by
PsilocybinAlpha
on Nov 25, 2020 7:58am
Q2 Results Nov 30; Conference Call Dec 1st 8am ET
The Company will conduct a conference call and webcast to review its results the following day, Tuesday, December 1, 2020 at 8:00 am ET. To access the call, please dial 1-877-407-9716 or 1-201-493
...more
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?